Idiopathic Membranous Nephropathy
📧 Sign up to get email alerts when something new happens for Idiopathic Membranous Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy [Phase 2]
A Phase 2 trial evaluating rituximab plus cyclosporine for idiopathic membranous nephropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria [Phase 2]
A Phase 2 clinical trial is evaluating AP1189 in patients with idiopathic membranous nephropathy who have nephrotic syndrome or severe prote…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Clinical Study of Anti-CD19/BCMA Universal Chimeric Antigen Receptor T Cells (UCAR-T) in the Treatment of Refractory Idiopathic Membranous Nephropathy (IMN) [EARLY_Phase 1]
An early-phase (Phase 1) clinical trial evaluating UCAR-T cells targeting CD19 and BCMA for refractory idiopathic membranous nephropathy; th…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Rivaroxaban in Idiopathic Membranous Nephropathy [Phase 4]
Ongoing Phase 4 clinical trial evaluating rivaroxaban for idiopathic membranous nephropathy; the study is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-12-09Clinical Trial Update: Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN [Phase 3]
A Phase 3 trial evaluating rituximab plus cyclosporine versus rituximab alone for idiopathic membranous nephropathy was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Different Immunosuppressive Treatment in iMN [Phase 3]
Phase 3 clinical trial evaluating different immunosuppressive regimens for idiopathic membranous nephropathy is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy [Phase 3]
Phase 3 trial of mycophenolate mofetil in progressive idiopathic membranous nephropathy has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Personalized Medicine for Membranous Nephropathy [Phase 2]
The document reports the completion of a Phase 2 clinical trial investigating personalized medicine for idiopathic membranous nephropathy.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome [Phase 3]
Phase 3 clinical study evaluating Rituximab for idiopathic membranous nephropathy with nephrotic syndrome is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy [Phase 2]
A Phase 2 comparison of LNP023 (iptacopan) versus Rituximab in idiopathic membranous nephropathy was terminated, and results have been poste…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy [Phase 4]
A Phase 4 clinical trial is ongoing to evaluate Huaier Granule for idiopathic membranous nephropathy, with recruitment currently in progress…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Multitarget Therapy for Idiopathic Membranous Nephropathy [Phase 4]
Phase 4 clinical trial investigating a multitarget therapy for idiopathic membranous nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy [Phase 3]
Phase 3 trial evaluating rituximab for idiopathic membranous nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: MEmbranous Nephropathy Trial Of Rituximab [Phase 2, Phase 3]
A phase 2/3 trial evaluating rituximab for idiopathic membranous nephropathy has completed with results available as of 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy [Phase 4]
A Phase 4 trial evaluating mycophenolate mofetil plus steroids for progressive idiopathic membranous nephropathy is underway, with unclear s…
-
CLINICAL_TRIALS withdrawal · 2017-03-22Clinical Trial Update: Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy [Phase 2]
A Phase 2 trial evaluating intravenous belimumab versus placebo for idiopathic membranous nephropathy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Study on the Therapeutic Effect of TCM Treatment for MDR MN [NA]
Clinical trial update on the therapeutic effect of traditional Chinese medicine for idiopathic membranous nephropathy; the current status is…
-
CLINICAL_TRIALS trial_result · 2015-10-27Clinical Trial Update: Rituximab in the Treatment of Idiopathic Membranous Nephropathy [EARLY_Phase 1]
This document reports on an early-phase Phase 1 clinical trial evaluating rituximab for idiopathic membranous nephropathy, with the study st…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy [Phase 1]
A Phase 1 dose-finding pilot study of adrenocorticotropic hormone (ACTH) in idiopathic membranous nephropathy has been completed.
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy [Phase 2]
Clinical trial update for a Phase 2 study evaluating steroids plus cyclosporin therapy in idiopathic membranous nephropathy.
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid [NA]
This document reports a completed clinical trial comparing Tripterygium wilfordii plus steroids versus tacrolimus plus steroids for idiopath…
-
CLINICAL_TRIALS research · 2013-04-23Clinical Trial Update: Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy
A clinical study is investigating a single-nucleotide polymorphism in idiopathic membranous nephropathy; the current status is not provided.
-
CLINICAL_TRIALS withdrawal · 2013-03-13Clinical Trial Update: Aliskiren in Patients With Idiopathic Membranous Nephropathy [NA]
A clinical trial evaluating aliskiren for idiopathic membranous nephropathy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy [Phase 2]
A Phase 2 clinical trial evaluating synthetic ACTH in high-risk patients with idiopathic membranous nephropathy has completed. The study was…
-
CLINICAL_TRIALS trial_result · 2012-02-03Clinical Trial Update: Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy [NA]
A completed clinical trial evaluating tacrolimus for idiopathic membranous nephropathy.